Debate Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments

被引：4
|
作者：
Kawaguchi, Yoshikuni [1 ,2 ]
De Bellis, Mario [1 ]
Panettieri, Elena [1 ]
Duwe, Gregor [1 ]
Vauthey, Jean-Nicolas [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 30卷 / 01期
基金：
美国国家卫生研究院;
关键词：
Colorectal liver metastasis; Resection; Chemotherapy; Molecular-targeted therapy; Conversion therapy; Two-stage hepatectomy; Neuroendocrine liver metastasis; Gastric liver metastasis; HEPATIC VEIN EMBOLIZATION; RANDOMIZED PHASE-III; COLORECTAL-CANCER; 2-STAGE HEPATECTOMY; GASTRIC-CANCER; NEUROENDOCRINE METASTASES; SURGICAL RESECTION; 1ST-LINE TREATMENT; MAJOR HEPATECTOMY; PLUS BEVACIZUMAB;
D O I：
10.1016/j.soc.2020.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：205 / 218
页数：14
相关论文
共 17 条
  • [1] Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments
    Kawaguchi, Yoshikuni
    De Bellis, Mario
    Panettieri, Elena
    Duwe, Gregor
    Vauthey, Jean-Nicolas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2025, 39 (01) : 207 - 220
  • [2] Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases
    Das, Satya
    Berlin, Jordan
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (01) : 189 - 204
  • [3] Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases
    Das, Satya
    Berlin, Jordan
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2025, 39 (01) : 191 - 206
  • [4] Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
    Zhang, Xing-Chen
    Zhou, Yu-Wen
    Wei, Gui-Xia
    Luo, Yi-Qiao
    Qiu, Meng
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [5] Locoregional therapy and systemic cetuximab to treat colorectal liver metastases
    Fiorentini, Giammaria
    Aliberti, Camillo
    Sarti, Donatella
    Coschiera, Paolo
    Tilli, Massimo
    Mulazzani, Luca
    Giordani, Paolo
    Graziano, Francesco
    Gonzalez, Alfonso Marques
    Marcos, Raul Garcia
    Mugnoz, Fernando Gomez
    Cantore, Maurizio
    Ricci, Stefano
    Catalano, Vincenzo
    Mambrini, Andrea
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (06) : 47 - 54
  • [6] Locoregional Liver-Directed Therapies to Treat Unresectable Colorectal Liver Metastases: A Review
    McFadden, Nikia R.
    Perry, Lauren M.
    Ghalambor, Tara J.
    Langan, Russell C.
    Gholami, Sepideh
    ONCOLOGY-NEW YORK, 2022, 36 (02): : 108 - 114
  • [7] Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
    Abdel-Rahman, Omar
    Cheung, Winson Y.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [8] Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation
    Thuluvath, Paul J.
    To, Chau
    Amjad, Waseem
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (01) : 57 - 67
  • [9] Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement
    Clary, Bryan M.
    Grothey, Axel
    Kopetz, Scott
    Marsh, Robert D. W.
    HPB, 2013, 15 (02) : 116 - 118
  • [10] Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
    Schwarz, Roderich E.
    Berlin, Jordan D.
    Lenz, Heinz J.
    Nordlinger, Bernard
    Rubbia-Brandt, Laura
    Choti, Michael A.
    HPB, 2013, 15 (02) : 106 - 115
12